Status:
TERMINATED
Disease Risk Reduction and Omega-3 Rich Rainbow Trout (Fish for Health)
Lead Sponsor:
USDA Grand Forks Human Nutrition Research Center
Conditions:
Obesity
Eligibility:
All Genders
20-70 years
Phase:
NA
Brief Summary
The purpose of this study is to determine how eating fish raised to have different levels of omega-3 fatty acids will reduce cardiovascular risk markers in people with elevated cardiovascular risk.
Detailed Description
Consumption of fish high in long chain omega-3 fatty acids (LCn3) is associated with reduction of cardiovascular disease (CVD) risk. CVD is a major cause of death in the United States. The current obe...
Eligibility Criteria
Inclusion
- BMI of 30 - 39.9 kg/m2
Exclusion
- Are allergic to fish
- Use tobacco products or nicotine in any form including snuff, pills, and patches, or e-cigarettes in the past 6 months
- Have established cardiovascular, pulmonary, and/or a metabolic disease such as diabetes
- Have uncontrolled high blood pressure
- Have alcohol, anabolic steroids, or other substance abuse issues
- Consume more than 3 alcoholic drinks/week
- Have cancer
- Are pregnant or nursing
- Take non-steroidal anti-inflammatory drugs such as aspirin, ibuprofen or Aleve, lipid modifying drugs such as statins, take medications for blood glucose such as insulin or metformin
Key Trial Info
Start Date :
June 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 25 2020
Estimated Enrollment :
29 Patients enrolled
Trial Details
Trial ID
NCT02204709
Start Date
June 1 2015
End Date
March 25 2020
Last Update
August 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
USDA Grand Forks Human Nutrition Research Center
Grand Forks, North Dakota, United States, 58203